Full Year 2021 Results


2021 Preliminary Results

2021 Preliminary Results

2021 Preliminary Results Presentation

Uniphar 2021 Prelim Results Presentation

FY 2021 Key Stats

€86.5m
EBITDA
8.5%
Organic GP Growth YoY
17.6%
ROCE 2021
16.2c
Adjusted EPS

Group Highlights

€274.5m

2021 GP

Employees
Partnering with 7 of the top 10 pharma companies
and 7 of the top 10 medical device companies

Investor News

23 December, 2021
www.irishtimes.com
by Ciara O'Brien
Uniphar announces three acquisitions in the UK and Ireland